Use of traditional medicine in treatment of migraine during coronavirus disease 2019 (COVID-19) pandemic: an online survey

Since the declaration of coronavirus disease 2019 (COVID-19) pandemic, patients with migraine were specifically vulnerable to worsening of their headaches. Traditional medicine (TM) has been used to treat headache disorders for centuries, especially during times of a healthcare emergencies, similar to the current pandemic. We aimed to assess the use of TM in treatment of migraine amid COVID-19 pandemic in Kuwait, using an online, self-administered questionnaire. A total of 1018 patients completed the survey. TM was used by 39.9% respondents. The greatest users of TM were those with older age (p =0.04), and longer disease duration (p =0.005). TM users were found to be more compliant to treatments than non-TM users (p<0.02). However, they reported significantly less communication with their physicians (p <0.001) during the pandemic. This study showed higher rates of TM use, as a way of self-treatment, among patients with migraine during COVID-19 pandemic. Neurologists should prepare their patients with "rescue" strategies for headache management, and new means of communication, to face these "new normal" challenges.